Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Shares Outstanding (Weighted Average) (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $20.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 3.8% to $20.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.1 million through Dec 2025, up 3.8% year-over-year, with the annual reading at $20.1 million for FY2025, 3.8% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $20.1 million in Q4 2025 for Ani Pharmaceuticals, roughly flat from $20.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $20.1 million in Q3 2025 to a low of $12.0 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $17.0 million across 5 years, with a median of $17.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 0.86% in 2021 and later soared 35.09% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $12.6 million in 2021, then grew by 29.09% to $16.3 million in 2022, then rose by 10.71% to $18.0 million in 2023, then increased by 7.32% to $19.3 million in 2024, then increased by 3.8% to $20.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ANIP at $20.1 million in Q4 2025, $20.1 million in Q3 2025, and $19.8 million in Q2 2025.